Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Feb-24 4:05 PM View:  | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale | 2,174 | $8.53 | $18,547.90 | (3%) 81.03K to 78.86K | |
| 02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale (Planned) | 2,590 | $8.86 | $22,947.40 | (3%) 78.86K to 76.27K | |
| 02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-24 | Grant | 25,000 | -- | -- | 45% 56.03K to 81.03K | |
| 25-Jan-24 4:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Jan-24 | Sale (Planned) | 2,062 | $8.96 | $18,475.50 | (4%) 58.1K to 56.03K | |
| 05-Sep-23 8:12 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Sep-23 | Sale (Planned) | 1,815 | $14.71 | $26,698.70 | (3%) 59.91K to 58.1K | |
| 05-Sep-23 8:12 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Aug-23 | Grant | 3,300 | -- | -- | 6% 56.61K to 59.91K | |
| 12-May-23 4:11 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-May-23 | Sale (Planned) | 825 | $16.59 | $13,686.80 | (1%) 57.44K to 56.61K | |
| 02-Feb-23 7:11 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-23 | Sale (Planned) | 2,590 | $22.25 | $57,627.50 | (4%) 60.03K to 57.44K | |
| 02-Feb-23 7:11 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-23 | Grant | 20,250 | -- | -- | 51% 39.78K to 60.03K | |
| 26-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-23 | Sale (Planned) | 2,062 | $21.50 | $44,333.00 | (5%) 41.84K to 39.78K | |
| 12-May-22 8:47 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-22 | Sale (Planned) | 1,050 | $21.51 | $22,584.50 | (2%) 42.89K to 41.84K | |
| 12-May-22 8:47 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-May-22 | Sale (Planned) | 900 | $21.51 | $19,359.00 | (2%) 43.79K to 42.89K | |
| 02-Feb-22 4:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Grant | 9,840 | -- | -- | 28% 35.3K to 45.14K | |
| 02-Feb-22 4:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Sale (Planned) | 1,350 | $27.40 | $36,990.00 | (3%) 45.14K to 43.79K | |
| 26-Jan-22 4:35 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-22 | Market Sale (Planned) | 2,250 | $24.98 | $56,205.00 | (6%) 37.55K to 35.3K | (12%) |
| 12-Jan-22 4:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Jan-22 | Sale (Planned) | 5,000 | $27.40 | $137,000.00 | (12%) 42.55K to 37.55K | |
| 12-Jan-22 4:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-Jan-22 | Grant | 5,000 | -- | -- | 13% 37.55K to 42.55K | |
| 13-May-21 4:09 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-21 | Market Sale (Planned) | 1,625 | $19.46 | $31,622.50 | (5%) 36.08K to 34.45K | < 1% |
| 13-May-21 4:09 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-21 | Market Sale (Planned) | 1,625 | $19.14 | $31,102.50 | (4%) 37.7K to 36.08K | (4%) |
| 09-Feb-21 4:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Feb-21 | Market Sale (Planned) | 2,250 | $31.58 | $71,055.00 | (6%) 39.95K to 37.7K | 2% |
| 09-Feb-21 4:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Feb-21 | Market Sale (Planned) | 2,250 | $31.41 | $70,672.50 | (5%) 42.2K to 39.95K | (1%) |
| 05-Feb-21 4:47 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Grant | 4,500 | -- | -- | 12% 37.7K to 42.2K | |
| 03-Feb-21 9:31 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Market Sale (Planned) | 3,175 | $28.91 | $91,789.20 | (8%) 40.88K to 37.7K | < 1% |
| 02-Feb-21 9:21 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Market Sale (Planned) | 3,175 | $30.75 | $97,631.20 | (7%) 44.05K to 40.88K | |
| 02-Feb-21 9:21 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-21 | Grant | 5,000 | -- | -- | 13% 39.05K to 44.05K | |
| 25-Jan-21 8:56 PM View: | Travere Therapeutics, Inc. (TVTX) | 21-Jan-21 | Grant | 15,000 | -- | -- | 62% 24.05K to 39.05K | |
| 07-Jan-21 6:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 06-Jan-21 | Market Sale (Planned) | 688 | $27.01 | $18,582.90 | (3%) 24.74K to 24.05K | < 1% |
| 07-Jan-21 6:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Jan-21 | Market Sale (Planned) | 688 | $26.65 | $18,335.20 | (3%) 25.43K to 24.74K | (1%) |
| 17-Nov-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Nov-20 | Market Sale (Planned) | 2,500 | $23.98 | $59,950.00 | (9%) 27.93K to 25.43K | |
| 13-Nov-20 9:26 PM View: | Travere Therapeutics, Inc. (TVTX) | 13-Nov-20 | Market Sale (Planned) | 2,500 | $23.62 | $59,045.50 | (8%) 30.43K to 27.93K | |
| 13-Nov-20 9:26 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Nov-20 | Grant | 5,000 | -- | -- | 20% 25.43K to 30.43K | |
| 23-Sep-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Sep-20 | Market Sale (Planned) | 1,500 | $18.48 | $27,720.00 | (6%) 26.93K to 25.43K | (5%) |
| 22-Sep-20 9:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 22-Sep-20 | Market Sale (Planned) | 1,500 | $18.59 | $27,885.00 | (5%) 28.43K to 26.93K | |
| 22-Sep-20 9:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-Sep-20 | Grant | 3,000 | -- | -- | 12% 25.43K to 28.43K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-20 | Market Sale | 527 | $16.98 | $8,950.73 | (2%) 26.48K to 25.96K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-20 | Market Sale (Planned) | 525 | $17.16 | $9,009.00 | (2%) 25.96K to 25.43K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-20 | Market Sale (Planned) | 525 | $14.95 | $7,848.75 | (2%) 27.01K to 26.48K | |
| 12-Mar-20 7:44 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-Mar-20 | Market Sale (Planned) | 3,500 | $15.02 | $52,570.00 | (11%) 30.51K to 27.01K | |
| 09-Mar-20 9:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Mar-20 | Grant | 3,500 | -- | -- | 13% 27.01K to 30.51K | |
| 31-Jan-20 8:17 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-20 | Grant | 9,000 | -- | -- | 50% 18.01K to 27.01K | |
| 08-Jan-20 9:01 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Jan-20 | Market Sale (Planned) | 750 | $15.14 | $11,355.00 | (4%) 18.76K to 18.01K | |
| 08-Jan-20 9:01 PM View: | Travere Therapeutics, Inc. (TVTX) | 07-Jan-20 | Market Sale (Planned) | 750 | $13.94 | $10,455.00 | (4%) 19.51K to 18.76K | |
| 16-May-19 9:35 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-19 | Market Sale (Planned) | 525 | $17.71 | $9,297.75 | (3%) 20.03K to 19.51K | (5%) |
| 16-May-19 9:35 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-May-19 | Market Sale (Planned) | 525 | $17.75 | $9,318.75 | (3%) 20.56K to 20.03K | (1%) |
| 10-May-19 9:42 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-19 | Grant | 6,000 | -- | -- | 41% 14.56K to 20.56K | |
| 13-Feb-19 8:50 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-Feb-19 | Market Sale (Planned) | 884 | $21.50 | $19,006.00 | (6%) 15.44K to 14.56K | (3%) |
| 13-Feb-19 8:50 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Feb-19 | Market Sale (Planned) | 885 | $21.38 | $18,921.30 | (5%) 16.33K to 15.44K | (< 1%) |
| 09-Jan-19 7:43 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-Jan-19 | Market Sale (Planned) | 750 | $23.82 | $17,865.00 | (4%) 17.08K to 16.33K | < 1% |
| 09-Jan-19 7:43 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Jan-19 | Market Sale (Planned) | 750 | $24.09 | $18,067.50 | (4%) 17.83K to 17.08K | 2% |
| 16-Nov-18 7:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-Nov-18 | Market Sale (Planned) | 2,500 | $24.33 | $60,816.00 | (12%) 20.33K to 17.83K | (2%) |